Literature DB >> 10684697

Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group.

G L Mutter1.   

Abstract

The diagnosis of precancerous lesions of the endometrium remains unstandardized because existing World Health Organization classification categories do not correspond to distinctive biologic groups and are inadequately supported by reproducible histopathologic criteria. A group of gynecologic pathologists was convened to consider revised diagnostic classification and criteria based on newly available information. We propose the terms endometrial hyperplasia (EH), endometrial intraepithelial neoplasia (EIN), and adenocarcinoma to define distinctive subgroups that are functionally relevant to clinical management of patients with endometrial disease. Endometrial precancers are collectively designated EIN in recognition of their monoclonal growth. At present there is no effective strategy for constructive subdivision of EIN lesions into grades or subgroups. EIN is to be distinguished from adenocarcinoma and the diffuse hormonal changes of EH seen in anovulation. An archive of genetically and morphologically classified endometrial precancers at www.endometrium.org provides a resource for centralized review of the histopathology of EIN lesions. A new architectural criterion for EIN diagnosis, diminution of stromal volume to less than approximately half of the total sample volume, will also assist in discriminating between EH and EIN. Implementation of this proposal will bring diagnostic terminology into agreement with current concepts of premalignant endometrial disease and facilitate more uniform patient management. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10684697     DOI: 10.1006/gyno.1999.5580

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  42 in total

Review 1.  EIN and WHO94.

Authors:  J P A Baak; G L Mutter
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

2.  Histologic diagnosis of endometrial hyperplasia.

Authors:  Jaime Prat
Journal:  Virchows Arch       Date:  2002-08-10       Impact factor: 4.064

3.  PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.

Authors:  Kimberly H Allison; Kristen Upson; Susan D Reed; Carolyn D Jordan; Katherine M Newton; Jennifer Doherty; Elizabeth M Swisher; Rochelle L Garcia
Journal:  Int J Gynecol Pathol       Date:  2012-03       Impact factor: 2.762

4.  Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.

Authors:  James V Lacey; George L Mutter; Marisa R Nucci; Brigitte M Ronnett; Olga B Ioffe; Brenda B Rush; Andrew G Glass; Douglas A Richesson; Nilanjan Chatterjee; Bryan Langholz; Mark E Sherman
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 5.  My approach to the interpretation of endometrial biopsies and curettings.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

6.  A New Classification of Benign, Premalignant, and Malignant Endometrial Tissues Using Machine Learning Applied to 1413 Candidate Variables.

Authors:  Michael J Downing; David J Papke; Svitlana Tyekucheva; George L Mutter
Journal:  Int J Gynecol Pathol       Date:  2020-07       Impact factor: 2.762

Review 7.  Management of endometrial precancers.

Authors:  Cornelia L Trimble; Michael Method; Mario Leitao; Karen Lu; Olga Ioffe; Moss Hampton; Robert Higgins; Richard Zaino; George L Mutter
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

8.  Endometrial hyperplasia: a clinicopathological study in a tertiary care hospital.

Authors:  Gargi Raychaudhuri; Anjali Bandyopadhyay; Dipnarayan Sarkar; Sarbeswar Mandal; Sajeeb Mondal; Pradip Kumar Mitra
Journal:  J Obstet Gynaecol India       Date:  2013-06-27

9.  Diagnosing endometrial hyperplasia: why is it so difficult to agree?

Authors:  Kimberly H Allison; Susan D Reed; Lynda F Voigt; Carolyn D Jordan; Kathryn M Newton; Rochelle L Garcia
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

10.  Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma.

Authors:  Snezana Pejić; Ana Todorović; Vesna Stojiljković; Jelena Kasapović; Snezana B Pajović
Journal:  Reprod Biol Endocrinol       Date:  2009-12-23       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.